Antibodies Against the Main Immunogenic Region of the Acetylcholine Receptor Correlate With Disease Severity in Myasthenia Gravis

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp-2012-302705
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Antigenic Role of Single Residues Within the Main Immunogenic Region of the Nicotinic Acetylcholine Receptor

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1990English

Deficiencies in Anti-Acetylcholine Receptor Antibody Measurement in Myasthenia Gravis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1991English

Circulating Regulatory Anti–T Cell Receptor Antibodies in Patients With Myasthenia Gravis

Journal of Clinical Investigation
Medicine
2003English

Infantile Onset Myasthenia Gravis With MuSK Antibodies

Pediatric Neurology Briefs
2006English

Determination of Acetylcholine Receptor Antibody in Myasthenia Gravis: Clinical Usefulness and Pathogenetic Implications.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1978English

Myasthenogenicity of the Main Immunogenic Region

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2012English

Antibody to Acetylcholine Receptor in Myasthenia Gravis: Prevalence, Clinical Correlates, and Diagnostic Value

Neurology
Neurology
2011English

A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells

Neurotherapeutics
NeurologyPharmacology
2016English

Rippling Muscle Disease With Myasthenia Gravis

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy